TOKYO, Jun 05 (Pulse News Wire) – GNI Group Ltd. (2160.T) announced changes to its major shareholder lineup following the acquisition of Ayumi Pharmaceuticals on June 05, 2026.
As part of the deal, GNI will issue new shares to BCP Asia AYM Holding (Cayman) L.P., making it the largest shareholder with 6,982,004 shares, representing approximately 14.89% of total outstanding voting rights post-issue. Prior to the transaction, BCP Asia AYM Holding did not hold any shares in GNI Group. Following the issuance of new shares, the total number of shareholders' voting rights will increase from 557,227 to 656,969.
The move is expected to take place between June 30, 2026, and September 30, 2026. BCP Asia AYM Holding, established based on exempt limited partnership regulations, is managed by Blackstone entities. Details such as capital contributions and investor ratios remain undisclosed due to confidentiality agreements.
GNI Group stated there would be no impact on its operational structure or performance as a result of this shareholding change.
🟢 Confidence: High AI-translated content.